Seasonal Malaria chemoprevention (SMC) is one of the large-scale life-saving malaria interventions initially recommended for the Sahel subregion, including Burkina Faso and recently extended to other parts of Africa. Initially, SMC was restricted to children 3 to 59 months old, but an extension to older children in some locations was recently recommended. Further characterization of SMC population profile beyond age criterion is necessary for understanding factors that could negatively impact the effectiveness of the intervention and to define complementary measures that could enhance its impact. Children were assessed through a cross-sectional survey during the first month of the 2020 SMC campaign (July-August 2020) as part of the SMC-NUT ...
This study was done to determine the effectiveness of Seasonal Malaria Chemoprevention in Senegalese...
Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) plus amodiaquine (AQ), gi...
BACKGROUND: In 2012, the WHO issued a policy recommendation for the use of seasonal malaria chemopre...
Background: Malaria and malnutrition remain major problems in Sahel countries, especially in young c...
Seasonal Malaria Chemoprevention (SMC), is recommended in the Sahel region of Africa for children un...
International audienceBackground: Previous controlled studies demonstrated seasonal malaria chemopre...
In 2014, the Burkina Faso government launched the Seasonal Malaria Chemoprevention (SMC) programme. ...
Background Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) plus amodiaqui...
Context Seasonal malaria chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine (SPAQ...
BACKGROUND: A recent trial in Burkina Faso and Mali showed that combining seasonal RTS,S/AS01E malar...
BackgroundSeasonal malaria chemoprevention (SMC) is recommended in the Sahel region of Africa for ch...
BackgroundMalnutrition and malaria are common co-morbidities in low-income countries, especially amo...
Seasonal malaria chemoprevention (SMC) is adopted and implemented in Senegal since 2013 in the south...
BackgroundSeasonal malaria chemoprevention (SMC) is recommended in the Sahel region of Africa for ch...
Malaria disproportionately affects all ages with a high burden among children below five years. Thus...
This study was done to determine the effectiveness of Seasonal Malaria Chemoprevention in Senegalese...
Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) plus amodiaquine (AQ), gi...
BACKGROUND: In 2012, the WHO issued a policy recommendation for the use of seasonal malaria chemopre...
Background: Malaria and malnutrition remain major problems in Sahel countries, especially in young c...
Seasonal Malaria Chemoprevention (SMC), is recommended in the Sahel region of Africa for children un...
International audienceBackground: Previous controlled studies demonstrated seasonal malaria chemopre...
In 2014, the Burkina Faso government launched the Seasonal Malaria Chemoprevention (SMC) programme. ...
Background Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) plus amodiaqui...
Context Seasonal malaria chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine (SPAQ...
BACKGROUND: A recent trial in Burkina Faso and Mali showed that combining seasonal RTS,S/AS01E malar...
BackgroundSeasonal malaria chemoprevention (SMC) is recommended in the Sahel region of Africa for ch...
BackgroundMalnutrition and malaria are common co-morbidities in low-income countries, especially amo...
Seasonal malaria chemoprevention (SMC) is adopted and implemented in Senegal since 2013 in the south...
BackgroundSeasonal malaria chemoprevention (SMC) is recommended in the Sahel region of Africa for ch...
Malaria disproportionately affects all ages with a high burden among children below five years. Thus...
This study was done to determine the effectiveness of Seasonal Malaria Chemoprevention in Senegalese...
Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) plus amodiaquine (AQ), gi...
BACKGROUND: In 2012, the WHO issued a policy recommendation for the use of seasonal malaria chemopre...